LSE - Delayed Quote GBp

Cambridge Cognition Holdings Plc (COG.L)

Compare
43.00
+1.00
+(2.38%)
At close: January 23 at 4:35:08 PM GMT

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
NameTitlePayExercisedYear Born
Mr. Rob Baker COO & Acting Joint MD -- -- --
Mr. Alex Livingstone-Learmonth Chief Commercial Officer & Acting Joint MD -- -- --
Mr. John Hammond Co-Founder -- -- --
Mr. Nick Taptiklis Head of Technology Strategy -- -- --
Ms. Francesca Cormack Ph.D. Chief Scientist & Member of Scientific Advisory Board -- -- --
Mr. Simon Merritt Marketing and Communications Director -- -- --
Dr. Lisa Elizabeth Nolan Ph.D. Vice President Business Development -- -- 1962
Ms. Nicky Ackerley Global HR Director -- -- --
Prof. Trevor Robbins CBE, FBPsS, FMedSci, FRS, Ph.D. Senior Consultant -- -- --
Prof. Barbara Sahakian FBPsS, FMedSci Senior Consultant -- -- --

Cambridge Cognition Holdings Plc

Tunbridge Court
Tunbridge Lane Bottisham
Cambridge, CB25 9TU
United Kingdom
https://www.cambridgecognition.com
Sector: 
Healthcare
Full Time Employees: 
119

Description

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval. It also offers eCOA, a data management tool for clinical scales which supports questionnaires and issue resolutions; and provides cognitive kit for detecting fluctuations in brain health. In addition, the company provides voice analysis tools for monitoring neurological and psychiatric disorders; eConsent, a patient consent solution; and Clinpal, an application for managing patients workflows. Further, it offers AQUA, a speech analysis platform for clinical scales. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.

Corporate Governance

Cambridge Cognition Holdings Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events